FDA inspection
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site): FDA inspection ending May 12, 2015
FDA inspection 937313 · Voluntary Action Indicated (VAI) · Nanjing
Key facts
| Inspection ID | 937313 |
|---|---|
| Firm | Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. (FDF Site) |
| FEI number | 3010625707 |
| Address | No. 16 Xuefu Rd., Nanjing High & New Technology Developmen |
| City | Nanjing |
| Country | China |
| Fiscal year | 2015 |
| Inspection end date | May 12, 2015 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data